Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations
Abstract Loss-of-function mutations in JAK1/2 can lead to acquired resistance to anti-programmed death protein 1 (PD-1) therapy. We reasoned that they may also be involved in pr...